Anxiety Disorder News and Research

RSS

Interim data from UCLA and NeuroSigma’s eTNS Phase I trial on PTSD, MDD

Today, at the 52nd annual New Clinical Drug Evaluation Unit (NCDEU) Conference in Arizona, Ian Cook, M.D., Professor of Psychiatry at the University of California, Los Angeles (UCLA) and a Senior Medical Advisor to NeuroSigma, Inc., presented the results from the first 6-subject cohort of a 10-subject Phase I open-label clinical trial studying the effects of external trigeminal nerve stimulation (eTNS) on Post-Traumatic Stress Disorder (PTSD) and depressive symptoms in Major Depressive Disorder (MDD) as an adjunct to pharmacotherapy.

31 May 2012

Reducing off-label antipsychotic use may generate savings with little impact on patient care

Reducing the non-FDA-approved use of antipsychotic drugs may be a way to save money while having little effect on patient care, according to a Penn State College of Medicine study.

16 May 2012

Simple two-question test more effective in identifying anxiety disorders in children

A University of British Columbia researcher has developed a simple two-question test to screen kindergarten-aged children for future anxiety disorders - the most commonly reported mental health concern among children.

17 Apr 2012

Intelligence may have co-evolved with worry in humans

Worrying may have evolved along with intelligence as a beneficial trait, according to a recent study by scientists at SUNY Downstate Medical Center and other institutions.

16 Apr 2012

Research roundup: Effects of health exchanges; Improving provider performance; Governors' 2013 budgets and Medicaid

Authors analyzed the cost and coverage implications of various scenarios of the health insurance exchanges that are called for in the health law. They predicted that about 1 million uninsured people in the state would get insurance through the exchanges and said that premiums in the small group and individual market would be lower than if the health law was not in effect.

7 Apr 2012

Teva, IVAX receive FDA approval for generic Lexapro to treat depression and GAD

The U.S. Food and Drug Administration today approved the first generic Lexapro (escitalopram tablets) to treat both depression and generalized anxiety disorder in adults.

27 Mar 2012

Teva gets exclusive 180 days to market generic antidepressant and anti-anxiety pill Lexapro

Teva Pharmaceutical Industries Ltd. Has won U.S. approval to sell the first generic version of Lexapro for depression and anxiety. Teva has been granted a 180-day exclusivity, so no other firm can market the generic medication in the United States in that timeframe, the Food and Drug Administration (FDA) said in a news release.

15 Mar 2012

Exercise training can reduce worry symptoms among GAD patients

This study demonstrates that exercise training, including resistance exercise training, is a feasible, low-risk treatment that can potentially reduce worry symptoms among generalized anxiety disorder (GAD) patients and may be an effective adjuvant, short-term treatment or augmentation for GAD.

15 Mar 2012

Teva commences commercial launch of Escitalopram Oxalate Tablets

Teva Pharmaceutical Industries Ltd. announced today that it has commenced commercial launch of Escitalopram Oxalate Tablets, the Company's generic version of Forest Laboratories' depression and generalized anxiety disorder treatment, Lexapro Tablets.

15 Mar 2012

Uncovering the science behind generations of mental illness

Sometimes the most interesting way to digest scientific information is within the context of personal experiences. Likewise, the story of someone's personal journey or struggle can take on broader significance when melded with the insights of scientific knowledge.

14 Mar 2012

Causal link between TBI and increased susceptibility to PTSD

Mild traumatic brain injury (TBI) and posttraumatic stress disorder (PTSD) are cardinal injuries associated with combat stress, and TBI increases the risk of PTSD development. The reasons for this correlation have been unknown, in part because physical traumas often occur in highly emotional situations.

22 Feb 2012

Traumatic brain injury linked to PTSD: UCLA study

UCLA life scientists and their colleagues have provided the first evidence of a causal link between traumatic brain injury and an increased susceptibility to post-traumatic stress disorder.

16 Feb 2012

Study finds no link between BDV and psychiatric illness

Over the past 30 years, numerous studies have linked Borna disease virus (BDV) with mental illnesses such as bipolar disorder, schizophrenia, anxiety disorder and dementia. Genetic fragments and antibodies to this RNA virus, which causes behavior disorders in a range of mammals and birds, have been found to be prevalent in psychiatric patients, but study results have been inconsistent. Now, the first blinded, case-control study to examine this issue finds no association between the virus and psychiatric illness.

1 Feb 2012

States redesigning mental health programs, coverage and care

States are grappling with mental health issues including a redesign of a program in Iowa, increased coverage for the mentally ill in California and a mental health first aid pilot program in Pennsylvania.

30 Jan 2012

Regular exercise can decrease anxiety symptoms in patients with GAD

Approximately 3 percent of the U.S. population suffers from excessive, uncontrollable worry that reduces their health and quality of life. The condition, known as Generalized Anxiety Disorder, is difficult to overcome and is accompanied by a host of physical symptoms, including fatigue, muscle tension, irritability and poor sleep. However, a new University of Georgia study shows that regular exercise can significantly reduce anxiety symptoms in patients with GAD.

20 Jan 2012

Children with chronic sleep problems may develop mental health disorders later in life

Children who have chronic sleep problems may be much more likely to develop mental health disorders as adolescents and adults, according to Candice Alfano, associate professor in clinical psychology at the University of Houston (UH) and director of the new Sleep and Anxiety Center for Kids (SACK).

11 Jan 2012

Individuals with mood and anxiety disorders may be more likely to abuse opioids

Individuals suffering from mood and anxiety disorders such as bipolar, panic disorder and major depressive disorder may be more likely to abuse opioids, according to a new study led by researchers from the Johns Hopkins Bloomberg School of Public Health. They found that mood and anxiety disorders are highly associated with non-medical prescription opioid use.

14 Dec 2011

U.S. DoD awards $11M to study two different ways to treat PTSD in war veterans

A team of researchers who have pioneered novel treatments for post-traumatic stress disorder (PTSD) has been awarded an $11 million, four-year grant from the U.S. Department of Defense to investigate the differences between virtual reality and traditional prolonged exposure therapy.

14 Dec 2011

Forest Laboratories second quarter net sales increase 9.0% to $1,130.3 million

Forest Laboratories, Inc., an international pharmaceutical manufacturer and marketer, announced that reported earnings per share equaled $0.91 in the second quarter of fiscal 2012. Reported earnings per share in the second quarter of fiscal 2011 were $1.00.

18 Oct 2011

Study sheds new light on relationship of anxiety and high blood pressure to primary aldosteronism

A study that has been published in the Journal of Clinical Endocrinology and Metabolism by an Italian group headed by Nicoletta Sonino (Padova) sheds some new light on the relationship of anxiety and high blood pressure to a hormonal disturbance, primary aldosteronism.

3 Oct 2011